Empagliflozin Tablets
Type 2 Diabetes Mellitus, Heart Failure
10mg · 25mg
Empagliflozin tablets for type 2 diabetes and heart failure. They lower blood sugar by letting the kidneys remove it in urine.
From$4.68/ tabletView
Empagliflozin
Empagliflozin (in Glyxambi) is an SGLT2 inhibitor used for type 2 diabetes and selected heart and kidney outcomes. This listing includes Empagliflozin Tablets and Glyxambi.
Key points
- SGLT2 inhibitor medicines cause the kidneys to remove more glucose in urine.
- Glyxambi combines empagliflozin with the DPP-4 inhibitor linagliptin.
- Important risks include ketoacidosis, dehydration, genital infections and urinary infections.
What empagliflozin is used for
Empagliflozin is used for Type 2 Diabetes Mellitus and can also be used in selected adults with Heart Failure or chronic kidney disease. In this listing, Empagliflozin Tablets carry the additional heart-related links, while Glyxambi is linked to type 2 diabetes. The tablets sit within Diabetes Management.
Further reading
Related articles
5 Aug 2026 ⋅ 9 min read
Ramadan and Your Medication: Timing, Fasting and What Not to Stop
Fasting changes when you take most medicines, not whether you need them. What to raise with your doctor before Ramadan, which medicines carry real risk during a fast, and why stopping a chronic medicine quietly is the dangerous option.
Read guide
5 Aug 2026 ⋅ 9 min read
Type 2 Diabetes: Why Early Diagnosis Matters More Than It Sounds
Type 2 diabetes symptoms can be mild enough to go unnoticed for years, so it is often diagnosed after complications have already started. What to watch for, what the treatments do, and why more than half of people with diabetes take no medication for it.
Read guide